Daiichi, Merck pull HER3-DXd filing at FDA after confirmatory trial misses survival endpoint

fiercebiotech.com/biotech/daiichi-merck-pull-her3-dxd-filing-fda-after-confirmatory-trial-misses-survival-endpoint

This story appeared on fiercebiotech.com, 2025-05-29 20:18:20.804000.
The Entire Business World on a Single Page. Free to Use →